Tandem Diabetes Care, Inc. (TNDM)
NASDAQ: TNDM · Real-Time Price · USD
21.37
-0.07 (-0.30%)
Aug 31, 2026, 10:02 AM EDT - Market open
Tandem Diabetes Care Stock Forecast
Stock Price Forecast
According to 24 analysts polled by S&P Global, Tandem Diabetes Care stock has a consensus rating of "Buy" and an average price target of $28.7. The average 1-year stock price forecast is 34.33% higher than the current stock price, while the lowest is $18 (-15.75%) and the highest is $50 (+134.03%).
Price Target: $28.7 (+34.33%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Tandem Diabetes Care stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 9 | 9 | 9 | 10 | 10 | 11 |
| Buy | 3 | 3 | 3 | 3 | 2 | 2 |
| Hold | 11 | 11 | 11 | 10 | 11 | 11 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 23 | 23 | 23 | 23 | 23 | 24 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| William Blair | William Blair | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Aug 21, 2026 |
| Citi | Citi | Hold Maintains $21 → $24 | Hold | Maintains | $21 → $24 | +12.33% | Aug 14, 2026 |
| Canaccord Genuity | Canaccord Genuity | Buy Maintains $40 | Buy | Maintains | $40 | +87.22% | Aug 12, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Hold Maintains $22 | Hold | Maintains | $22 | +2.97% | Aug 7, 2026 |
| Lake Street | Lake Street | Buy Reiterates $50 | Buy | Reiterates | $50 | +134.03% | Aug 7, 2026 |
Financial Forecast
Revenue This Year
1.07B
from 1.01B
Increased by 5.68%
Revenue Next Year
1.21B
from 1.07B
Increased by 12.40%
EPS This Year
-0.67
from -2.58
EPS Next Year
0.17
from -0.67
EPS and Forward PE are based on non-GAAP adjusted numbers.